ABT-806 derived antibody drug conjugates (ADCs) inhibit growth of malignant mesothelioma in-vivo.
Conference Paper
-
- Overview
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
publication date
has subject area
published in
presented at event
Identity
Digital Object Identifier (DOI)
Additional Document Info
Publisher
-
American Society of Clinical Oncology (ASCO)
start page
end page
volume
issue